Developed against corona virus Oxford-AstraZeneca vaccine, “Does it cause blood clotting?” on the agenda with the question.
The European Medicines Agency (EMA) made a statement regarding the Covid-19 vaccine developed by Oxford University and AstraZeneca.
The European Medicines Agency accepted claims for the vaccine, which was suspended in many countries due to concerns that it could cause blood clotting. It has been said that the blood coagulation seen in the patients is related to AstraZeneca.
The agency, which repeatedly stated that the benefits of the vaccine outweigh the possible side effects, abandoned this decision. After the European Medicines Agency (EMA) announced that the AstraZeneca vaccine was “safe and effective”, many countries started using the vaccine again.
GERMANY STOPPED USE FOR UNDER 60
The German Permanent Vaccination Commission (STIKO) has updated its recommendation on the AstraZeneca vaccine, recommending that the AstraZeneca vaccine be administered only to citizens over 60 years of age. Federal and state health ministries, following STIKO’s advice, have decided that the AstraZeneca vaccine is only used for women and men over the age of 60 across the country.
The use of the Dutch vaccine has completely stopped
In the Netherlands, the Health Services Association affiliated with the municipalities announced that the use of the AstraZeneca vaccine was completely stopped due to side effects and deaths in the incoming reports.
MORE THAN 20 COUNTRIES SUSPENDED VACCINES
France, Denmark, Germany, Netherlands, Iceland, Luxembourg, Portugal, Slovenia, Ireland, Norway, Italy, Austria, Estonia, Lithuania, Latvia, Bulgaria, Romania, Thailand, Indonesia, Luxembourg, Spain, Greek Cypriot Administration (GCASC) and More than 20 countries, including Sweden, suspended the use of the corona virus vaccine produced by AstraZeneca on suspicion of causing blood clotting.
VIDEO: CAN VACCINES BE EFFECTIVE? (ARCHIVE)